1. Skip to content

Mesothelioma Cancer Resources Blog

  • AllTrials Fights for Clinical Trial Transparency

    Clinical trials are critically important to mesothelioma patients, and MesotheliomaHelp strives to bring key trial information to our readers. Today, we are following up on a previous article on the report from Duke University about trial results being underreported, with information regarding a global campaign undertaken to fix this problem. For rare diseases, such as …

    Label: Featured Story

    Posted on Thursday, Apr 16, 2015
  • Lung Cancer and Mesothelioma Patients May Benefit from the MD Anderson and Oncoceutics, Inc. Partnership

    The University of Texas MD Anderson Cancer Center is on a mission “to eliminate cancer in Texas, the nation, and the world.” In another step towards meeting that goal, it has joined forces with a pharmaceutical company to collaborate in the clinical development of a novel anti-cancer drug shown in preclinical studies to be effective …

    Label: Featured Story

    Posted on Monday, Apr 13, 2015
  • CRS-207 Receives Orphan Drug Designation for Treatment of Pleural Mesothelioma

    Aduro Biotech, Inc. announced last month that the U.S. Food and Drug Administration has granted orphan drug designation to its anti-cancer drug, CRS-207, a novel immuno-oncology product candidate, for the treatment of mesothelioma. “This is an important step for Aduro as we continue to develop CRS-207 for this very difficult to treat cancer,” said Dirk …

    Label: Featured Story

    Posted on Thursday, Apr 9, 2015
Load More News